Please enable Javascript in your Browser to experience full features of this website.
AIDSinfo Logo
AIDS
info
Mobile
|
1-800-HIV-0440
|
Contact Us
|
En Español
Search Here:
skip navigation
Home
Guidelines
Antiretroviral Treatment
Adult and Adolescent ARV Guidelines
Pediatric ARV Guidelines
Maternal-Child Transmission
Perinatal Guidelines
Management of HIV Complications
Adult and Adolescent OI Prevention and Treatment Guidelines
Pediatric OI Prevention and Treatment Guidelines
Care for Disaster Displaced HIV-Infected Patients
Guidelines on Care for HIV-Infected Residents Displaced from Disaster Areas
Preexposure Prophylaxis
Preexposure Prophylaxis (PrEP) Guidelines
Postexposure Prophylaxis
Occupational Postexposure Prophylaxis (PEP) Guidelines
Nonoccupational Postexposure Prophylaxis (nPEP) Guidelines
Prevention
HIV Counseling, Testing, and Referral Guidelines
Guidelines on Incorporating HIV Prevention into Medical Care
Search the Guidelines
Please Select a Guideline
Adult and Adolescent Guidelines
Pediatric Guidelines
Perinatal Guidelines
Search Guidelines
Clinical Trials
Clinical Trials Search Options
Search by Keyword
Search by Category
Select a topic
Cancer
Coinfections
Complications/Side Effects
Opportunistic Infections
Prevention Research
Specific Populations
Treatment Research
Vaccine Research
Trials by Age
Trials by Study Type
Search by Topics
Select a subtopic
Advanced Search
Download Education Materials
What is an HIV/AIDS Clinical Trial (PDF)
Preventive HIV Vaccines (PDF)
Therapeutic HIV Vaccines (PDF)
Drugs
FDA-approved
Combination Drugs
Entry and Fusion Inhibitors
Integrase Inhibitors
Non-nucleoside Reverse Transcriptase Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Opportunistic Infections
Protease Inhibitors
Investigational
Entry and Fusion Inhibitors
Integrase Inhibitors
Non-nucleoside Reverse Transcriptase Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Search HIV/AIDS Drugs
Alphabetical Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All Drugs
HIV/AIDS Health Topics
HIV/AIDS-Related Guidelines
Staying Healthy with HIV
Specific Populations
Treatment Resources
HIV/AIDS-Related Conditions
Prevention Research
General Information
Clinical Research
For Health Care Providers
For Researchers
Search HIV/AIDS Health Topics
Alphabetical Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All Topics
Education Materials
Glossary
HIV and Its Treatment Fact Sheet (PDF)
Pregnancy Fact Sheet (PDF)
More Fact Sheets
HIV/AIDS Awareness Day Pages
Search the Glossary
(Other Education Materials not included)
Alphabetical Glossary Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All Glossary Terms
Mobile Resources & Tools
Mobile Site
Apps
APIs
Widgets
Order Publications
Skip Nav
HIV/AIDS News
Home
>
HIV/AIDS News
> HIV/AIDS News Search Results
Small
Medium
Large
Text Size
HIV/AIDS News Search Results
10 news items were found. [Date: March 1, 1996 - March 31, 1996]
Search Terms
From:
RadDatePicker
Calendar
Title and navigation
<<
<
February 2013
>
>>
February 2013
S
M
T
W
T
F
S
27
28
29
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
1
2
3
4
5
6
7
8
9
To:
RadDatePicker
Calendar
Title and navigation
<<
<
February 2013
>
>>
February 2013
S
M
T
W
T
F
S
27
28
29
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
1
2
3
4
5
6
7
8
9
Genetic Markers May Influence Disease-Free Interval in HIV-Infected People
Date: March 28, 1996
Source: National Institutes of Health (NIH)
http://aidsinfo.nih.gov/news/236/genetic-markers-may-influence-disease-free-interval-in-hiv-infected-people/
FDA Approves First Test for HIV Antigen Screening of Blood Donors
Date: March 14, 1996
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/234/fda-approves-first-test-for-hiv-antigen-screening-of-blood-donors/
FDA Grants Accelerated Approval To Third Protease Inhibitor To Treat HIV
Date: March 14, 1996
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/233/fda-grants-accelerated-approval-to-third-protease-inhibitor-to-treat-hiv/
FDA Panel Recommends Approval of Third Protease Inhibitor
Date: March 8, 1996
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/232/fda-panel-recommends-approval-of-third-protease-inhibitor/
ACTG 152: New Insights Into Pediatric Antiretroviral Therapy
Date: March 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/278/actg-152-new-insights-into-pediatric-antiretroviral-therapy/
CPCRA 007: Preliminary Results of Combination Antiretroviral Study
Date: March 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/277/cpcra-007-preliminary-results-of-combination-antiretroviral-study/
FDA Approves Second Protease Inhibitor to Treat HIV
Date: March 1, 1996
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/231/fda-approves-second-protease-inhibitor-to-treat-hiv/
Highlights of AIDS Vaccine Meeting
Date: March 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/281/highlights-of-aids-vaccine-meeting/
Journal Watch
Date: March 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/280/journal-watch/
Studies Examine Relationship of Viral Load to Maternal HIV Transmission
Date: March 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/279/studies-examine-relationship-of-viral-load-to-maternal-hiv-transmission/